These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 28322294)

  • 61. Efficacy and safety of DPP-IV inhibitors combined with basal insulin in the treatment of type 2 diabetes.
    Pan Z; Yang Y; Zhang J
    J Diabetes; 2020 Oct; ():. PubMed ID: 33016503
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alogliptin: a DPP-4 inhibitor modulating adipose tissue insulin resistance and atherogenic lipid.
    Kutoh E; Kuto AN; Akiyama M; Ozawa E; Kurihara R
    Eur J Clin Pharmacol; 2023 Jul; 79(7):947-959. PubMed ID: 37193913
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessment of pancreatic β-cell function: review of methods and clinical applications.
    Cersosimo E; Solis-Herrera C; Trautmann ME; Malloy J; Triplitt CL
    Curr Diabetes Rev; 2014 Jan; 10(1):2-42. PubMed ID: 24524730
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning.
    Rameshrad M; Razavi BM; Ferns GAA; Hosseinzadeh H
    Daru; 2019 Jun; 27(1):341-360. PubMed ID: 30674032
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysis.
    Barkas F; Elisaf M; Tsimihodimos V; Milionis H
    Diabetes Metab; 2017 Feb; 43(1):1-8. PubMed ID: 27916514
    [TBL] [Abstract][Full Text] [Related]  

  • 66. DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: A meta-analysis.
    Yang Y; Cai Z; Zhang J
    PLoS One; 2021; 16(5):e0251916. PubMed ID: 34015003
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes.
    Wang X; Zheng P; Huang G; Yang L; Zhou Z
    Clin Exp Med; 2018 Nov; 18(4):473-480. PubMed ID: 30022375
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis.
    Bae J; Kim G; Lee YH; Lee BW; Kang ES; Cha BS
    Diabetes Ther; 2019 Feb; 10(1):149-158. PubMed ID: 30506494
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.
    Wang N; Yang T; Li J; Zhang X
    Diabetes Metab Syndr Obes; 2019; 12():1513-1526. PubMed ID: 31692532
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus.
    Wei X; Bai Y; Wang Z; Zheng X; Jin Z; Liu X
    Diabetol Metab Syndr; 2021 Aug; 13(1):88. PubMed ID: 34446063
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Uric acid lowering improves insulin sensitivity and lowers blood pressure: a meta-analysis of randomized parallel-controlled clinical trials.
    Zong Q; Ma G; Wang T
    Afr Health Sci; 2021 Mar; 21(1):82-95. PubMed ID: 34394285
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Efficacy and safety of vitamin D for type 2 diabetes mellitus: a systematic review].
    Gao W; Chen DW; Liu GJ; Ran XW
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1401-6. PubMed ID: 24025505
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dipeptidyl peptidase-4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin-secreting capacity, a higher body mass index and insulin resistance.
    Kozawa J; Kitamura T; Nishizawa H; Yasuda T; Maeda N; Otsuki M; Okita K; Iwahashi H; Kaneto H; Funahashi T; Imagawa A; Shimomura I
    J Diabetes Investig; 2013 Mar; 4(2):190-4. PubMed ID: 24843651
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes.
    Pelluri R; Kongara S; Nagasubramanian VR; Mahadevan S; Chimakurthy J
    J Endocrinol Invest; 2023 May; 46(5):855-867. PubMed ID: 36624224
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of vitamins C and E on insulin resistance in diabetes: a meta-analysis study.
    Khodaeian M; Tabatabaei-Malazy O; Qorbani M; Farzadfar F; Amini P; Larijani B
    Eur J Clin Invest; 2015 Nov; 45(11):1161-74. PubMed ID: 26313310
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of Proton-Pump Inhibitors on Glucose and Insulin Metabolism on Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Sánchez-García A; Simental-Mendía M; Simental-Mendía LE
    Curr Pharm Des; 2020; 26(32):4007-4013. PubMed ID: 32445448
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Simental-Mendía LE; Simental-Mendía M; Sánchez-García A; Banach M; Atkin SL; Gotto AM; Sahebkar A
    Pharmacol Res; 2018 Jun; 132():232-241. PubMed ID: 29292213
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association between dipeptidyl peptidase-4 inhibitor drugs and risk of acute pancreatitis: A meta-analysis.
    Chen S; Zhao E; Li W; Wang J
    Medicine (Baltimore); 2017 Dec; 96(48):e8952. PubMed ID: 29310393
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The healthy Nordic diet for blood glucose control: a systematic review and meta-analysis of randomized controlled clinical trials.
    Zimorovat A; Mohammadi M; Ramezani-Jolfaie N; Salehi-Abargouei A
    Acta Diabetol; 2020 Jan; 57(1):1-12. PubMed ID: 31172295
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes.
    Pinheiro MM; Pinheiro FMM; Diniz SN; Fabbri A; Infante M
    Int Immunopharmacol; 2021 Jun; 95():107518. PubMed ID: 33756226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.